HOUSTON, Dec. 3, 2020 /PRNewswire/ — Eceptionist a world leader in providing healthcare organizations with cloud-based software solutions for referral management, scheduling, and telehealth, announces the release and availability of VaxManager – a SAAS solution specifically designed to help small and large organizations manage the last step of the COVID-19 vaccine distribution to patients and citizens. VaxManager has been designed to alleviate the administrative burden of managing COVID testing, COVID vaccines (when available) and flu shots, all while improving the patient experience with easy-to-use self-service tools. VaxManager offers:
VaxManager is designed to work for small and large private and public health organizations, pharmacies, employers, universities, school districts, churches and any other groups that participate in the distribution of vaccines to patients and citizens. VaxManager service is now available for onboarding.
Eceptionist (www.eceptionist.com) is a leading provider of software solutions for the health care industry with a cloud-based platform for referral management, e-consults, streamlined scheduling, and overall telehealth management. Since 2001, Eceptionist has been helping clients reduce costs and optimize the delivery of healthcare services. Utilizing the Eceptionist family of services, organizations can better manage healthcare delivery across departments, health systems and regions. The Eceptionist platform supports intelligent scheduling, telemedicine, intelligent referrals, triage and wait time management for facilities and hospitals around the world.
All questions and inquiries should be directed to https://eceptionist.com/contact-us/ or 713.520.6688.
View original content:http://www.prnewswire.com/news-releases/eceptionist-announces-the-release-of-vaxmanager-service-301185361.html
SOURCE Eceptionist, Inc.
Research highlights how nutrition tracking drives success for weight loss and health goals NEW YORK,…
Coeptis Aims to Bring AI Innovation in Biotechnology and Technology WEXFORD, Pa., Dec. 26, 2024…
Slovenia, Croatia, Turkey, and Greece Drive EHR Adoption in the Balkans, Setting New Standards in…
Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…